COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: www.coronavirus.gov
Get the latest grant and research information from NIH: www.nih.gov/coronavirus

NIH staff guidance on coronavirus (NIH Only): https://employees.nih.gov/pages/coronavirus

Kidney Disease Section

of the Kidney Diseases Branch

Jeffrey B. Kopp, M.D.

Section Chief

jeffrey.kopp@nih.gov

Clinical and translational researchers who seek deeper understanding and new therapies for glomerular disease, including membranous nephropathy and FSGS.

About Our Research

Select Publications

APOL1 renal risk variants exacerbate podocyte injury by increasing inflammatory stress.: Wakashin H, Heymann J, Roshanravan H, Daneshpajouhnejad P, Rosenberg A, Shin MK, Hoek M, Kopp JB.; BMC Nephrol (2020 Aug 27) 21:371. Abstract/Full Text
Podocytopathies.: Kopp JB, Anders HJ, Susztak K, Podestà MA, Remuzzi G, Hildebrandt F, Romagnani P.; Nat Rev Dis Primers (2020 Aug 13) 6:68. Abstract/Full Text

View More Publications

Lab Members Clinical Trials Research Materials Glomerular Disease Primer